Zura Bio (ZURA) Earnings Date & Reports

Zura Bio Ltd is a clinical-stage biotechnology company developing novel medicines for patients with autoimmune and inflammatory diseases, including serious and debilitating conditions with unmet medical need... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ZURA is expected to report earnings to fall 10.33% to -18 cents per share on November 18

Q3'26

Est.

$-0.19

Q2'26

Missed

by $0.02

Q1'26

Missed

by $0.03

Q4'25

Missed

by $0.19

Q3'25

Beat

by $0.14

The last earnings report on August 11 showed earnings per share of -20 cents, missing the estimate of -18 cents. With 1.25M shares outstanding, the current market capitalization sits at 392.90M.

View a ticker or compare two or three

ZURA

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for ZURA